Skip to search.
 TSX Down 0.03% TSX Ventures Up 0.42%

ZIOPHARM Oncology, Inc. (ZIOP)

-NasdaqCM
7.06 Down 0.04(0.56%) May 26, 4:00PM EDT
Prev Close:7.10
Open:7.15
Bid:6.67 x 100
Ask:8.60 x 100
1y Target Est:7.00
Beta:2.46121
Earnings Date:Aug 8 - Aug 12 (Est.)
Day's Range:6.94 - 7.20
52wk Range:4.56 - 14.93
Volume:1,405,964
Avg Vol (3m):2,613,980
Market Cap:919.37M
P/E (ttm):N/A
EPS (ttm):-0.42
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ZIOPDown 0.56%919.37M
IMGNDown 3.91%491.99M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):153.35
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.43
Quarterly EPS Est (Jun-16) :-0.11
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ZIOPHARM Oncology, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing a portfolio of cancer therapies that address unmet medical needs through synthetic immuno-oncology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback